266 related articles for article (PubMed ID: 28829588)
1. Apigenin Restrains Colon Cancer Cell Proliferation via Targeted Blocking of Pyruvate Kinase M2-Dependent Glycolysis.
Shan S; Shi J; Yang P; Jia B; Wu H; Zhang X; Li Z
J Agric Food Chem; 2017 Sep; 65(37):8136-8144. PubMed ID: 28829588
[TBL] [Abstract][Full Text] [Related]
2. The interaction between apigenin and PKM2 restrains progression of colorectal cancer.
Shi J; Ji X; Shan S; Zhao M; Bi C; Li Z
J Nutr Biochem; 2023 Nov; 121():109430. PubMed ID: 37597817
[TBL] [Abstract][Full Text] [Related]
3. Scutellarin inhibits Hela cell growth and glycolysis by inhibiting the activity of pyruvate kinase M2.
You L; Zhu H; Wang C; Wang F; Li Y; Li Y; Wang Y; He B
Bioorg Med Chem Lett; 2017 Dec; 27(24):5404-5408. PubMed ID: 29157862
[TBL] [Abstract][Full Text] [Related]
4. Secreted pyruvate kinase M2 facilitates cell migration via PI3K/Akt and Wnt/β-catenin pathway in colon cancer cells.
Yang P; Li Z; Wang Y; Zhang L; Wu H; Li Z
Biochem Biophys Res Commun; 2015 Apr; 459(2):327-332. PubMed ID: 25732087
[TBL] [Abstract][Full Text] [Related]
5. Pyruvate kinase M2 facilitates colon cancer cell migration via the modulation of STAT3 signalling.
Yang P; Li Z; Fu R; Wu H; Li Z
Cell Signal; 2014 Sep; 26(9):1853-62. PubMed ID: 24686087
[TBL] [Abstract][Full Text] [Related]
6. PKM2 depletion induces the compensation of glutaminolysis through β-catenin/c-Myc pathway in tumor cells.
Wu H; Li Z; Yang P; Zhang L; Fan Y; Li Z
Cell Signal; 2014 Nov; 26(11):2397-405. PubMed ID: 25041845
[TBL] [Abstract][Full Text] [Related]
7. Tannic acid directly targets pyruvate kinase isoenzyme M2 to attenuate colon cancer cell proliferation.
Yang P; Ding GB; Liu W; Fu R; Sajid A; Li Z
Food Funct; 2018 Nov; 9(11):5547-5559. PubMed ID: 30259036
[TBL] [Abstract][Full Text] [Related]
8. Beta-elemene inhibits breast cancer metastasis through blocking pyruvate kinase M2 dimerization and nuclear translocation.
Pan Y; Wang W; Huang S; Ni W; Wei Z; Cao Y; Yu S; Jia Q; Wu Y; Chai C; Zheng Q; Zhang L; Wang A; Sun Z; Huang S; Wang S; Chen W; Lu Y
J Cell Mol Med; 2019 Oct; 23(10):6846-6858. PubMed ID: 31343107
[TBL] [Abstract][Full Text] [Related]
9. PTBP1 knockdown overcomes the resistance to vincristine and oxaliplatin in drug-resistant colon cancer cells through regulation of glycolysis.
Cheng C; Xie Z; Li Y; Wang J; Qin C; Zhang Y
Biomed Pharmacother; 2018 Dec; 108():194-200. PubMed ID: 30219676
[TBL] [Abstract][Full Text] [Related]
10. Enhancing 5-fluorouracil efficacy through suppression of PKM2 in colorectal cancer cells.
Cao Y; Lin Y; Wang D; Pan D; Zhang Y; Jin Y; Zheng C
Cancer Chemother Pharmacol; 2018 Dec; 82(6):1081-1086. PubMed ID: 30155759
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antitumor activity of novel 2, 3-didithiocarbamate substituted naphthoquinones as inhibitors of pyruvate kinase M2 isoform.
Ning X; Qi H; Li R; Jin Y; McNutt MA; Yin Y
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):126-129. PubMed ID: 29185365
[TBL] [Abstract][Full Text] [Related]
12. Kaempferol Reverses Aerobic Glycolysis via miR-339-5p-Mediated PKM Alternative Splicing in Colon Cancer Cells.
Wu H; Cui M; Li C; Li H; Dai Y; Cui K; Li Z
J Agric Food Chem; 2021 Mar; 69(10):3060-3068. PubMed ID: 33663206
[TBL] [Abstract][Full Text] [Related]
13. Metabolic and Proliferative State of Vascular Adventitial Fibroblasts in Pulmonary Hypertension Is Regulated Through a MicroRNA-124/PTBP1 (Polypyrimidine Tract Binding Protein 1)/Pyruvate Kinase Muscle Axis.
Zhang H; Wang D; Li M; Plecitá-Hlavatá L; D'Alessandro A; Tauber J; Riddle S; Kumar S; Flockton A; McKeon BA; Frid MG; Reisz JA; Caruso P; El Kasmi KC; Ježek P; Morrell NW; Hu CJ; Stenmark KR
Circulation; 2017 Dec; 136(25):2468-2485. PubMed ID: 28972001
[TBL] [Abstract][Full Text] [Related]
14. Specific Pyruvate Kinase M2 Inhibitor, Compound 3K, Induces Autophagic Cell Death through Disruption of the Glycolysis Pathway in Ovarian Cancer Cells.
Park JH; Kundu A; Lee SH; Jiang C; Lee SH; Kim YS; Kyung SY; Park SH; Kim HS
Int J Biol Sci; 2021; 17(8):1895-1908. PubMed ID: 34131394
[TBL] [Abstract][Full Text] [Related]
15. Pyruvate kinase type M2 is upregulated in colorectal cancer and promotes proliferation and migration of colon cancer cells.
Zhou CF; Li XB; Sun H; Zhang B; Han YS; Jiang Y; Zhuang QL; Fang J; Wu GH
IUBMB Life; 2012 Sep; 64(9):775-82. PubMed ID: 22807066
[TBL] [Abstract][Full Text] [Related]
16. 2'-hydroxycinnamaldehyde inhibits cancer cell proliferation and tumor growth by targeting the pyruvate kinase M2.
Yoon YJ; Kim YH; Jin Y; Chi SW; Moon JH; Han DC; Kwon BM
Cancer Lett; 2018 Oct; 434():42-55. PubMed ID: 30009856
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol inhibits cancer cell metabolism by down regulating pyruvate kinase M2 via inhibition of mammalian target of rapamycin.
Iqbal MA; Bamezai RN
PLoS One; 2012; 7(5):e36764. PubMed ID: 22574221
[TBL] [Abstract][Full Text] [Related]
18. Pyruvate kinase M2: multiple faces for conferring benefits on cancer cells.
Tamada M; Suematsu M; Saya H
Clin Cancer Res; 2012 Oct; 18(20):5554-61. PubMed ID: 23071357
[TBL] [Abstract][Full Text] [Related]
19. Lapachol inhibits glycolysis in cancer cells by targeting pyruvate kinase M2.
Shankar Babu M; Mahanta S; Lakhter AJ; Hato T; Paul S; Naidu SR
PLoS One; 2018; 13(2):e0191419. PubMed ID: 29394289
[TBL] [Abstract][Full Text] [Related]
20. Pyruvate kinase M2 accelerates pro-inflammatory cytokine secretion and cell proliferation induced by lipopolysaccharide in colorectal cancer.
Yang P; Li Z; Li H; Lu Y; Wu H; Li Z
Cell Signal; 2015 Jul; 27(7):1525-32. PubMed ID: 25778902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
